Transitioning from Lupus Low Disease Activity State to remission in systemic lupus erythematosus: real-world evidence
Achieving rapid remission after LLDAS attainment remains challenging for most SLE patients, mainly due to difficulties in reducing prednisone dosage to ≤5 mg/day.
Authors
- Yong Fan (ORCID: https://orcid.org/0000-0001-5003-9876)
- Lanlan Ji (ORCID: https://orcid.org/0000-0001-9620-8882)
- Dai Gao (ORCID: https://orcid.org/0000-0002-7982-8112)
- Zhuoli Zhang (ORCID: https://orcid.org/0000-0001-7219-9141)
- Yanjie Hao (ORCID: https://orcid.org/0000-0001-8715-259X)
- Wenhui Xie
- Xiaohui Zhang (ORCID: https://orcid.org/0000-0003-0245-6792)
Institutions
- Peking University (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.3389/fimmu.2025.1546306
- Citations
- 1
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 1.67